SCHEMBL4146554

SCHEMBL4146554

[O-][n+]1c(-c2ccccc2)cccc1-c1cccc2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.44
ALDH1A1 P00352 4/20 0.44
MAPT P10636 2/20 0.44
HPGD P15428 2/20 0.44
ATM Q13315 2/20 0.44
TP53 P04637 1/20 0.44
TSHR P16473 1/20 0.44
NFKB1 P19838 1/20 0.44
MAPK1 P28482 1/20 0.44
NFKB2 Q00653 1/20 0.44
RELA Q04206 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
HSD17B10 Q99714 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
CA12 O43570 3/20 0.40
CA1 P00915 3/20 0.40
CA2 P00918 3/20 0.40
CA9 Q16790 3/20 0.40
TNF P01375 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4144064 0.79 ALDH1A1 (0.44) KDM4EALDH1A1ATMMAPK1SMN1; SMN2
SCHEMBL14164166 0.76 CA12 (0.38) KDM4EALDH1A1HPGDTSHRHSD17B10
Biphenyl SCHEMBL1073325 0.75 ALDH1A1 (0.55) KDM4EALDH1A1MAPTHPGDATM
SCHEMBL29399206 0.75 TNF (0.61) KDM4EALDH1A1MAPTHPGDATM
SCHEMBL27988223 0.75 TNF (0.61) KDM4EALDH1A1MAPTHPGDATM
SCHEMBL69345 0.75 TNF (0.61) KDM4EALDH1A1MAPTHPGDATM
Methane SCHEMBL29181734 0.73 TNF (0.59) KDM4EALDH1A1MAPTHPGDATM
Hydrogen Sulfide SCHEMBL29156136 0.73 TNF (0.59) KDM4EALDH1A1MAPTHPGDATM
Biphenyl SCHEMBL28372188 0.73 ALDH1A1 (0.53) KDM4EALDH1A1MAPTHPGDATM
Ammonia Solution, Strong SCHEMBL28321869 0.73 TNF (0.59) KDM4EALDH1A1MAPTHPGDATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8952207-B2 Copper-catalyzed C—H bond arylation THE UNIVERSITY OF HOUSTON SYSTEM (US) 2015-02-10 US disclosed
US-8952207-B2 Copper-catalyzed C—H bond arylation THE UNIVERSITY OF HOUSTON SYSTEM (US) 2015-02-10 US disclosed
US-20090076266-A1 COPPER-CATALYZED C-H BOND ARYLATION THE UNIVERSITY OF HOUSTON SYSTEM (US) 2009-03-19 US disclosed
US-20090076266-A1 COPPER-CATALYZED C-H BOND ARYLATION THE UNIVERSITY OF HOUSTON SYSTEM (US) 2009-03-19 US disclosed
US-20090076266-A1 COPPER-CATALYZED C-H BOND ARYLATION THE UNIVERSITY OF HOUSTON SYSTEM (US) 2009-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090076266-A1 COPPER-CATALYZED C-H BOND ARYLATION AOC2, AOC3, DBH KDM4E 4036/4885ALDH1A1 44/4885MAPT 1901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.